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In the present study, we investigated the influence of 
resveratrol on PhIP treated human colon cancer cells and 
compared the effect to HaCaT cells considered as nor-
mal, human keratinocytes. Our results show that resvera-
trol decreases DNA damage induced by PhIP in both cell 
types, it increases the sensitivity of LoVo cells to apop-
tosis and has no effect on PhIP-treated HaCaT cells. We 
confirm that PhIP-induced apoptosis is p53 and caspase 
3/7 dependent. Interestingly, normal cells such as HaCaT 
are more resistant to PhIP treatment.
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INTRODUCTION
Colorectal carcinoma (CRC) is the fourth most com-
monly diagnosed cancer and the third most likely to 
cause death in the World. Diet plays an important role 
in etiology of colon cancer. Many studies indicate that 
high overall consumption of red and processed meat 
increases the risk of colorectal cancer (Zandonai et al., 
2012; Kim et al., 2011; Chan et al., 2011). It is estimated 
that 70% of CRC cases could be avoided due to diet 
modifications. Based on the analysis of the available 
data, in 2007 the World Cancer Research Fund recom-
mended the consumption of no more than 300 g of 
unprocessed red meat (beef, pork, goat, lamb) per week 
(World Cancer Research Fund/American Institute for 
Cancer Research, 2007). Research suggests that the re-
lationship between meat consumption and the risk of 
colorectal cancer may be associated with the process of 
its preparation because higher risk of colorectal cancer is 
observed in people who consume meat cooked at high 
temperatures for a long time (Sinha et al., 1999). This 
suggests the role of substances that are created during 
grilling or frying meat, meat products and fish, among 
other HCA – heterocyclic aromatic amines such as PhIP 
(2amino-3-methyl-3H-imidazo[4,5-f]quinoline) (Sugimu-
ra, 1997; Robbana-Barnat et al., 1996). The amount of 
PhIP formed depends on the type of food as well as 
the method, temperature and processing time (Skog et 
al., 1995). The total amount of HCA formed is estimated 
to be 10.89 ng per 1 g of heat-treated meat at 195°C 
(Puangsombat et al., 2012). In much smaller quantities, 
HCA are also present in environmental pollution and 
tobacco smoke (Manabe et al., 1991). There are many 
reports of the dietary effect of PhIP on increasing the 
incidence of human colorectal adenoma (Rohrmann 
et al., 2009), renal cells carcinoma (Daniel et al., 2012), 
rectal cancer (Ferrucci et al., 2012), and esophagus can-
cer (Cross et al., 2011). PhIP in a native form, delivered 
with food, does not have any carcinogenic effect. How-
ever, the metabolism of this substance which occurs in 
the human body, increases its toxicity. PhIP metabolism 
occurs via the liver CYP1A2, and via CYP1A1/1B1 in 
other tissues. Conjugation with glucuronide by means of 
UGT (UDP-glucuronyltransferase) enzymes or reduction 
by NADPH reductase results in detoxification, while the 
enzyme reaction from SULT groups (NAT) (N-acetyl-
transferases) leads to the formation of N-sulfonyloxy-
PhIP and N-acetoxy-PhIP which are very reactive and 
toxic compounds that form adducts with DNA, which 
may lead to impairment of the replication process, point 
mutations and chromosomal aberrations (Holme et al., 
1989). Also, the results of the last meta-analysis suggest 
that there is a positive association of HCAs mutagenicity 
index with the risk of colorectal adenomas (CRA) which 
are precursors of CRC. Additionally, this dose-response 
analyses showed an increased risk for CRA in the case 
of PhIP and mutagenicity index (Martínez Góngora et 
al., 2019). One can try to limit the amount of PhIP con-
sumed by changing the eating habits, but it is difficult to 
eliminate PhIP completely. Fortunately, the diet may also 
abound in compounds with opposite beneficial effects, 
referred to as nutraceuticals, which currently include 
many substances, such as cruciferous indoles, carrot ca-
rotenoids, black and green tea polyphenols, curcumin or 
resveratrol from red wine (De Silva & Lanerolle, 2011).
Resveratrol (3,5,4′-trihydroxystilbene, Res) is a natu-
ral polyphenol belonging to the class of stilbenes. Res 
is a nontoxic phytoalexin synthesized de novo by several 
plants in response to stress, injury, UV irradiation and 
pathogen infections (Singh et al., 2015). Resveratrol pos-
sesses a wide range of biological properties, among them 
antioxidative, cardioprotective, neuroprotective, anti-in-
flammatory, and anticancer (Galiniak et al., 2019; Fan et 
al., 2009; Duarte et al., 2015). Anticancer properties of 
resveratrol have been confirmed by many in vitro and in 
vivo studies, which show that resveratrol is able to inhibit 
all carcinogenesis stages (i.e., initiation, promotion, and 
progression) (Varoni et al., 2016; Pezzuto, 2008). Glob-
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ally, many in vitro and animal-based studies have demon-
strated preventive anticancer activity in colon, cervical, 
prostate, breast, and lungs (Zulueta, 2015; Whitlock & 
Baek, 2012; Lin et al., 2011).
In the present study, we investigated the influence of 
resveratrol on PhIP treated human colon cancer cells 
and compared the effect on HaCaT cells considered 
as normal human keratinocytes. Our results show that 
PhIP-induced apoptosis is caspase 3/7 dependent and 
normal cells are more resistant to it. Interestingly, while 
resveratrol decreases DNA damage in both cell types, it 
increases the sensitivity of LoVo cells to apoptosis and 
has no effect on PhIP-treated HaCaT cells.
MATERIALS AND METHODS
Cell lines and the treatment. Human colorectal can-
cer cell line LoVo (ATCC, USA) and human keratino-
cyte cell line HaCaT (Cell Lines Service GmbH, Eppel-
heim, Germany) were cultured in DMEM supplemented 
with 10% FBS (Lonza) in a humidified atmosphere at 
37°C and 5% CO2. Cells were passaged at c.a. 70–80% 
of confluence, and were routinely tested for mycoplas-
ma infection using a PCR-based method. The cells were 
treated with DMSO or PhIP (0–100 µM), resveratrol 
(5 µM) for 6–72 hours. Resveratrol and PhIP were dis-
solved in DMSO and stored at –20°C. Final concentra-
tions of compounds used for different experiments were 
prepared by diluting the stock with DMEM. Control cul-
tures received the carrier solvent (0.1% DMSO).
Comet assay. The level of DNA damage was deter-
mined by the electrophoresis of single cells in agarose 
gel as earlier described (Karabasz et al., 2018). Briefly, 
the cell suspension was mixed with low melting point 
agarose, set on slides, lysed and neutralized in appropri-
ate buffers.
Electrophoresis was performed at 23 V (0.74 V/cm, 
300 mA) for 30 min at 4°C. All stages of the experi-
ment were carried out in the dark to avoid any addition-
al DNA damage. Prior to the analysis, the slides were 
stained with propidium iodide (2.5 µg/ml). The analysis 
of DNA damage was carried out with COMET PLUS 
2.9 software (Comet Plus, Theta System Gmbh, Germa-
ny). The percentage content of DNA in the comet’s tail 
(DNA damage) was determined from 100 random im-
ages of comets per slide. Each experimental point was 
run in triplicate.
Cell cytotoxicity and apoptosis assays. For MTT 
cell viability assay, Thiazolyl Blue Tetrazolium Bromide 
(MTT, Sigma) was added for 60 min at a final concen-
tration of 500 ng/ml. The medium was removed by 
suction and MTT crystals were dissolved in DMSO: 
EtOH (1:1). The absorbance was measured at 560 nm 
a plate reader (Tecan Genios, Männedorf, Switzerland) 
(Wolnicka-Głubisz et al., 2005).
Caspase 3/7 activity was measured using Caspase-
Glo 3/7 Assay (Promega, Madison, USA) as described 
previously (Skalniak et al., 2018). Combined annexin V/ 
7-amino-actinomycin D (7AAD) staining was performed 
according to the manufacturer’s protocol followed by 
their analysis using a FACScan instrument (BD). All the 
resulting data was analyzed using the BD Cell Quest pro 
software (version 5.2.1, BD).
Western blotting. Total cell lysates were prepared 
with RIPA buffer (Sigma-Aldrich, Missouri, US) contain-
ing protease inhibitor cocktail (Sigma-Aldrich, Missouri, 
US) and PhosSTOP Phosphatase Inhibitor Cocktail (Sig-
ma-Aldrich, Missouri, US). Following the electrophore-
sis and transfer, PVDF membranes (Millipore, Billerica, 
MA, USA) were blocked with 4% bovine serum albumin 
(BSA, Sigma-Aldrich, Missouri, US) in TBS-N buffer and 
incubated with primary antibody at 4°C overnight. After 
three washes, the incubation with secondary antibody 
(1h at room temperature) and additional three washes, 
the detection was performed using Clarity Western ECL 
Substrate (Bio-Rad, California, USA) with the ChemiDoc 
(Bio-Rad, California, USA) detector and ImageLab 5.2.1. 
software.
The following antibodies and dilutions were used: 
p-Erk1/2, Erk1/2, p21 (1:2 000, Cell Signaling Tech-
nology, cat. 9101S, 9102S, 2947S), p53 (1:2 000, SCBt, 
cat. sc-6243), GAPDH (1:4 000, Cell Signaling Technol-
ogy, cat. 2118S), goat peroxidase-conjugated anti-rabbit 
(1:4 000, Cell Signaling Technology, cat. 7074), and goat 
peroxidase-conjugated anti-mouse (1:4 000, BP Pharmin-
gen, cat. 554002).
Statistics. All results are the means of at least three 
independent experiments ± standard deviation (S.D.). 
The data was analyzed using Student’s t-test. The comet-
assay with one-way ANOVA with Tukey’s post-hoc test 
was applied in Statistica 10 software (StatSoft). Statistical 
significance was accepted at the level of p<0.05.
RESULTS
Resveratrol reduces PhIP-induced DNA damage but 
does not affect metabolic activity
PhIP induced DNA damage in both LoVo (15% vs. 
control 6%) and HaCaT cells (25% vs. control 6%) 1 h 
after the treatment (Fig. 1A, B) which led to 50% reduc-
tion of metabolic activity measured by MTT assay 48 h 
after the treatment (Fig. 1A, B). Although resveratrol 
inhibited DNA damage induced by PhIP in the stud-
ied cell lines by 26% and 23%, respectively, it did not 
increase metabolic activity of PhIP-treated LoVo cells, 
while it did in HaCaT 24–28 h after the treatment. Res-
veratrol used in the present study at a concentration of 
5 µM had no effect on DNA damage or metabolic ac-
tivity of any of the cell lines used (Fig. 1A, B).
PhIP induces apoptosis of LoVo cells but not HaCaT
Caspase 3/7 activity and annexin-V–FITC /7AAD 
double staining were performed to analyze cell death 
induced by PhIP in LoVo and HaCaT cells. Fig-
ure 2A and C illustrates that PhIP activated caspase 
3/7 in LoVo (by 3 fold), but not in HaCaT cells up to 
48 h following the treatment. Analysis of Annexin V-
FITC/7AAD-stained cells confirmed the increase of the 
percentage of apoptotic and necrotic cells among PhIP-
treated LoVo cells (33%±5%), while in HaCaT cells the 
effect was much weaker (9±2%, Fig. 2D). This was fur-
ther confirmed by the inhibition of ERK 1/2 phospho-
rylation, a component in the apoptotic pathway. ERK 
activity has been associated with markers of apoptosis, 
like effector caspase-3 activation, poly(ADP-ribose) poly-
merase (PARP) cleavage, annexin-V staining, and DNA 
fragmentation (Wang et al., 2000).
PhIP-induced apoptosis is enhanced by resveratrol
Curcumin reduced PhIP induced apoptosis in 
MCF-7 cells (Jain et al., 2015), therefore we decided to 
verify if resveratrol, another polyphenol, has similar or 
reverse effect on LoVo and HaCaT cells. Resveratrol 
alone had no effect on caspase 3/7 activity, but in the 
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presence of PhIP it induced faster (6 h after the treat-
ment) and almost twice as much activation compared to 
PhIP alone (24–48 h after the treatment) in LoVo cells 
(Fig. 2A). However, PhIP alone or in combination with 
Res has no significant effect on caspase 3/7 activation 
in HaCaT cells (Fig. 2B). Annexin V/7AAD revealed 
that only in LoVo cells resveratrol enhanced the PhIP-
induced apoptosis by about 12% (Fig. 2C).
ERK 1/2, one of the MAPK, controls both prolifera-
tive and apoptotic signals in cells (Schevzov et al., 2015). 
PhIP decreased phospho-p44/42 MAPK (Erk 1/2) in 
LoVo by about 50% and by about 80% in HaCaT cells 
(Fig. 3), indicating that PhIP inhibits cell proliferation 
48 h after treatment. The presence of resveratrol had 
no impact on the PhIP reduced levels of P-ERK 1/2 
(Fig. 3).
PhIP alone or in combination with resveratrol increas-
es the expression of p53 in both cell lines 48h after the 
treatment (Fig. 4). This effect is stronger in LoVo cells 
which are wild-type for p53. HaCaT cell line contains 
a dysfunctional or only partially functional p53 (Muth-
usamy & Piva, 2013). The treatment of LoVo cells with 
a control compound, idasanutlin (RG7388), led to the 
increase of p53 level and the level of p21, the protein 
product of a well-known p53-regulated gene. Although 
PhIP alone with or without Res strongly increase level 
of p53 in LoVo cells, it has no effect on p21 (Fig. 4). 
We have shown previously that treating HaCaT cells 
with idasanutlin, which is a strong inducer of p53 activ-
ity, does not lead to an increase of p21 protein (Skalniak 
et al., 2018). Resveratrol has weak effect on PhIP-in-
duced p53 level.
DISCUSSION
Resveratrol is known for its antioxidant, chemo pre-
ventative, antimutagenic properties (Holme et al., 1989; 
Martínez Góngora et al., 2019). It is also an inducer of 
apoptosis in multiple cancer cells (Zhao et al., 2018; 
Wang et al., 2018; Li et al., 2019). However, the high 
concentrations that were used in these studies (around 
50 µM) are hard to be reached in physiological condi-
tions due to low bioavailability of resveratrol (Almeida et 
al., 2009; Cottart et al., 2010).
In this work, we investigated the effects of resvera-
trol on PhIP-treated LoVo and HaCaT cells, as PhIP is 
a known carcinogenic and mutagenic agent, and both 
compounds are present in our diet. We use a low con-
centration of resveratrol (5 µM) which itself has no ef-
fect on cell viability, metabolic activity or apoptosis and 
can be achieved physiologically. For example, Boocock et 
al. showed that after oral administration of 5 g of resver-
atrol in blood serum a concentration of 2.4 μM was ob-
tained (Boocock et al., 2007). In vitro data showed that a 
minimum of 5 µM resveratrol is required for the chemo 
preventive effects to be elicited (Boocock et al., 2007).
Previous reports have shown that human CYP1A2 
is particularly efficient to metabolically process PhIP to 
toxic species, such as N-hydroxy derivatives. Subsequent 
metabolic esterification generates potent DNA damag-
Figure 1. Resveratrol reduced PhIP-induced DNA damage but did not increase the viability of PhIP-treated cells. 
DNA damage by comet assay 1 h after the treatment with PhIP (100 µM) or/with resveratrol (Res, 5 µM) (left). MTT assay 24–72 h after 
the treatment (right). 1A – LoVo cells, 1B – HaCaT cells. The graphs show mean ± S.D. from three independent experiments. For the sta-
tistics t-test was performed: p<0.05, *vs. control (0.1% DMSO), **vs. PhIP treated cells.
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ing species (Buonarati et al., 1990) which are responsible 
for single and double DNA strain breaks detected in the 
comet assay. We found that DNA damage is more pro-
nounced in HaCaT (25% of DNA in comet tails) than 
LoVo cells (15%) which may suggest higher level of CY-
P1A2 in these cells. Although the main mechanisms by 
which PhIP induced DNA damage is adduct formation, 
the role of reactive oxygen (ROS) cannot be excluded.
As previously indicated, 10 µM resveratrol attenuates 
the mutagenicity of PhIP in hamster V79 cells (Boyce 
et al., 2004). Dubuisson showed that 50 μM resveratrol 
decreases the PhIP DNA adducts by 31–69% in pri-
mary cultures of human mammary epithelial cells and 
suppressed O-acetyltransferase and sulfotransferase ac-
tivities in the breast cancer cell lines MCF-7 and ZR-
75-1 (Dubuisson et al., 2002). We confirmed that PhIP 
induces DNA damage within the hour after the treat-
ment. In our study, addition of 5 μM resveratrol inhib-
its PhiP-induced DNA damage by about 25% in both 
cell lines.
PhIP (100 µM) induced a higher level of DNA 
damage in HaCaT and a higher percentage of meta-
bolically inactive cells 24 h after the treatment, but 
the viability of the LoVo and HaCaT cells 48 h after 
the treatment remains similar (50%), which may sug-
gest that HaCaT cells repair their DNA faster or have 
a more efficient detoxification activity (4-OH PhIP 
derivative) than LoVo, which could be worth verify-
ing. Resveratrol had no effect on untreated and PhIP-
treated LoVo cells but slightly increased viability of 
PhIP-treated HaCaT cells, measured by MTT assay. 
The decrease of viability induced by PhIP was accom-
Figure 2. PhIP induced apoptosis in LoVo cells but not in HaCaT cells. 
Caspase 3/7 activity at 6, 24 and 48 h after the treatment (A, B). Annexin V-FITC/7AAD double staining of cells (C, D). Graphs represent 
mean values of three independent experiments ± S.D.
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Figure 3. PhIP decreases ERK 1/2 activation. 
The expression of indicated protein by western blot 48 h after the treatment with PhIP (100 µM), resveratrol (Res; 5 µM), or both 
(PhIP+Res).
Figure 4. Expression of p53 and p21 48 h after the treatment with PhIP (100 µM), resveratrol (Res; 5 µM) or both (PhIP+Res), as 
shown by the western blot analysis. 
Positive control – RG7388 (5 µM for 6 h). The graph shows means ± S.E. from three independent experiments, presented as fold change 
versus control. For the statistics the t-test was performed: P<0.05, *vs. control (DMSO), **vs. PhIP.
610           2020K. Kurylowicz and others
panied by an inhibition of ERK 1/2 phosphorylation, 
a decrease in ERK, and an increase in apoptosis. Res-
veratrol has no effect on ERK 1/2 activation in LoVo 
or HaCaT cells, neither treated nor untreated. An-
nexin V staining of PhIP -treated cells revealed higher 
percentage of Annexin V+ in LoVo cells (42%) than 
in HaCaT cells (10%). Interestingly, resveratrol in-
creases percentage of Annexin V in LoVo cells up to 
50% but has weak effect on HaCaT, suggesting the 
involvement of various pathways.
It has previously been shown that PhIP induced 
DNA damage is p53 dependent in mice (Krais et al., 
2016), and that PhIP leads to apoptosis via p53/p21 
pathway in MCF-10A, which is induced by DNA 
damage (Gooderham et al., 2007). The tumor suppres-
sor p53 is a multifunctional transcription factor that 
drives the expression of genes for growth arrest, DNA 
repair, senescence, and apoptosis (Oren, 2003). In-
deed, we found p53 increase level 48h after treatment 
in PhIP treated cells but not at earlier time points. 
HaCaT cells lack functional p53/p21 signaling (Skalni-
ak et al., 2018) what could explain their resistance 
to PhIP-induced apoptosis if this is the only mech-
anism. LoVo cells are wild-type for p53 and have a 
functional p53/p21 signaling what we have confirmed 
using RG 7388, an MDM2 antagonist. However, we 
did not detect any changes in p21 level up to 72 h, 
which may suggest that p53 activates the transcription 
of pro-apoptotic genes other than p21WAF1 in these 
cells or that a second pathway is activated in which 
p53 activates the transcription of TNF-receptor fami-
ly, which requires verification. The binding of a ligand 
to its cognate receptor initiates this pathway through 
the formation of the death-inducing signaling complex 
that activates the initiator caspase-8, which proceeds 
to activate the effector caspase-3 and -7 to induce ap-
optosis (Guicciardi & Gores, 2009). Indeed, we found 
activation of caspase 3/7 in LoVo but not in HaCaT 
cells 24–48 h after PhIP treatment.
Interestingly, the presence of resveratrol induced fast-
er (upon 6 h) and significantly stronger caspase 3/7 ac-
tivation in LoVo cells and has no effect on caspase 3/7 
activation in HaCaT cells.
Our studies may suggest that diet rich in resveratrol 
could protect an organism from PhIP induced mutagenic 
effects by reducing DNA-induced damage and directing 
of cancer cells to apoptosis, and increasing normal cells 
viability. However this conclusion requires further verifi-
cation in in vivo model.
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